Suppression of tumour-specific cytotoxic T-cell responses against the syngeneic BALB/c plasmacytoma ADJ-PC-5 by tumour-induced CD8+ regulatory T cells via IFN-γ

Scandinavian Journal of Immunology

Volumn 43, Issue 4, 1996, Pages 421-430

  Pauels, H G ^a   Specht, C ^a   Becker, C ^a   Kolsch E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MOUSE; NONHUMAN; PHENOTYPE; PLASMACYTOMA; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0029883586     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-56.x     Document Type: Article

References (30)

1. Hentschel R, Kölsch E. Analysis of the growth characteristics of a primary BALB/c IgG plasmacytoma. Int J Cancer 1983:31:749-56.
2. Sulitzeanu D. Immunosuppressive factors in human cancer. Adv Cancer Res 1993:60:247-67.
3. Browning MJ, Bodmer WF. MHC antigens and cancer: Implications for T-cell surveillance. Curr Opin Immunol 1992:4:613-18.
4. Fujimoto S, Greene MI, Sehon AH. Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol 1976:116:791-9.
5. Naor D. Suppressor cells: permitters and promoters of malignancy? Adv Cancer Res 1979:29:45-125.
6. Glaser M. Indomethacin-sensitive suppressor cells regulate the cell-mediated cytotoxic response to SV 40-induced tumor-associated antigens in mice. Eur J Immunol 1980:10:489-95.
7. Ting C-C, Rodrigues D. Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance. Proc Natl Acad Sci 1980:77:4265-9.
8. Lala PK, McKenzie IFC. An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions. Immunology 1982:47:663-7.
9. + effector T cells. J Exp Med 1984:159:1295-311.
10. Haubeck H-D, Kölsch E. Regulation of immune response against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. IV. Tumor-specific T suppressor cells, induced at early stages of tumorigenesis, act on the induction phase of the tumor-specific cytotoxic T cell response. Immunobiology 1986:171:357-65.
11. Cihak J, Ziegler HW, Kölsch E. Regulation of immune response against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells. Immunology 1981:43:145-52.
12. Haubeck H-D, Kölsch E. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. III. Induction of specific T suppressor cells to the BALB/ c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis. Immunology 1982:47:503-10.
13. Blatt C, Haimovich J. Cell surface immunoglobulins of murine plasma cell tumors. Immunochemistry 1977:14:687-92.
14. Old LJ, Boyse EA, Clarke DA, Carswell EA. Antigenic properties of chemically induced tumors. II. Antigens of tumor cells. Ann NY Acad Sci USA 1962:101:80-106.
15. Thierfelder S, Cobbold S, Kummer U, Waldmann U, Schuh R. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement. Exp Hematol 1985:13:948-55.
16. Spitalny GL, Havell EA. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 1984:159:1560-5.
17. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986:136:2348-57.
18. Baniyasch M, Eshhar Z. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur J Immunol 1984:14:799-807.
19. Wilhelm M, Pechumer H, Rank G, Kopp E, Riethmüller G, Rieber EP. Direct monoclonal antibody rosetting. An effective method for weak antigen detection and large scale separation of human mononuclear cells. J Immunol Meth 1986:90:89-96.
20. Gillis S, Ferm MM, Ou W, Smith KA. T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 1978:120:2027-32.
21. Pierce JH, Difioré PP, Aaranson SA et al. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL 3 dependence by a nonautocrine mechanism. Cell 1985:41:685-93.
22. Rolink AG, Melchers F, Palacios R. Monoclonal antibodies reactive with the mouse interleukin 5 receptor. J Exp Med 1989:169:1693-701.
23. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 1986:83:9679-83.
24. Vogel SN, English KE, O'Brian AD. Silica enhancement of murine endotoxin sensitivity. Infect Immunol 1982:38:681-5.
25. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Meth 1993:159:197-207.
26. Bonmassar E, Goldin A, Cudkowicz G. Differential reactivity of mice to alloantigens associated with the D and K end of H-2: preliminary studies with bone marrow and lymphoma grafts. Transplantation 1971:12:314-18.
27. Günther J, Haas W, von Boehmer H. Suppression of T cell responses through competition for T cell growth factor (interleukin 2). Eur J Immunol 1982:12:247-9.
28. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunology Today 1985:6:131-6.
29. + T cells: their activation and effector functions. Curr Oppin Immunol 1994:6:453-7.
30. + T cells secreting Th1 or Th2 cytokines. Immunity 1995:2:271-9.